Prostate cancer-highlights from American Society of Clinical Oncology virtual meeting 2020.
作者信息
Naqos Nora, Kaikani Wafaa
机构信息
Department of Medical Oncology, Mohammed VI University Hospital of Marrakech, Morocco.
Department of Medical Oncology, Casablanca Cancer Center, University Mohammed VI des Sciences de la Santé, Morocco.
出版信息
Asian J Urol. 2022 Jul;9(3):282-286. doi: 10.1016/j.ajur.2021.10.005. Epub 2022 Jun 27.
Abstract
摘要
相似文献
1
Prostate cancer-highlights from American Society of Clinical Oncology virtual meeting 2020.前列腺癌——2020年美国临床肿瘤学会虚拟会议要点
Asian J Urol. 2022 Jul;9(3):282-286. doi: 10.1016/j.ajur.2021.10.005. Epub 2022 Jun 27.
2
Highlights in advanced prostate cancer from the 2013 American Urological Association Annual Meeting and the 2013 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2013 Sep;11 Suppl 14(9):2-15.
3
Highlights in advanced prostate cancer from the 2013 American Urological Association Annual Meeting and the 2013 American Society of Clinical Oncology Annual Meeting: commentary.
Clin Adv Hematol Oncol. 2013 Sep;11 Suppl 14(9):16-22.
4
Highlights from the 41st Annual Meeting of the American Society of Clinical Oncology, May 2005, and the 2005 American Society of Clinical Oncology Prostate Cancer Symposium, February 2005, Orlando, Florida.2005年5月美国临床肿瘤学会第41届年会以及2005年2月于佛罗里达州奥兰多市召开的美国临床肿瘤学会前列腺癌研讨会亮点。
Clin Prostate Cancer. 2005 Jun;4(1):7-14. doi: 10.1016/s1540-0352(11)70098-1.
5
Highlights in advanced prostate cancer from the 2012 American Urological Association Annual Meeting and the 2012 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2012 Aug;10(8 Suppl 12):1-24.
6
Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2011 Aug;9(8 Suppl 21):1-24.
7
Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.在美国临床肿瘤学会2016年年会展示的脑转移瘤研究进展：第一部分。
Future Oncol. 2016 Nov;12(22):2535-2538. doi: 10.2217/fon-2016-0341. Epub 2016 Sep 5.
8
More highlights in prostate cancer from the 2023 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2023 Aug;21(8):435-436.
9
Highlights in advanced prostate cancer from the 2021 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol. 2021 Aug;19 Suppl 18(8):1-24.
10
Highlights in advanced prostate cancer from the 2021 American Society of Clinical Oncology Annual Meeting: commentary.
Clin Adv Hematol Oncol. 2021 Aug;19 Suppl 18(8):18-23.
本文引用的文献
1
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.转移性去势敏感性前列腺癌中依泽替米贝联合雄激素剥夺治疗的疗效：ARCHES 事后分析。
J Urol. 2021 May;205(5):1361-1371. doi: 10.1097/JU.0000000000001568. Epub 2020 Dec 28.
2
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.口服瑞戈非尼在晚期前列腺癌中的雄激素剥夺治疗。
N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29.
3
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.ARCHES：雄激素剥夺治疗联合恩扎卢胺或安慰剂治疗转移性去势敏感性前列腺癌的随机 III 期研究。
J Clin Oncol. 2019 Nov 10;37(32):2974-2986. doi: 10.1200/JCO.19.00799. Epub 2019 Jul 22.
4
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.达罗他胺用于非转移性去势抵抗性前列腺癌。
N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14.
Zotero 插件